Claya vs Vytora Health
An in-depth comparison of two leading GLP-1 Providers
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Claya
Best for compounded GLP-1 in injectable and oral-tablet forms with named cliniciansStarting at $179/mo
Vytora Health
Best for compounded or brand-name GLP-1 with named pharmacy partners, 50 statesStarting at $150/mo
Side-by-Side Comparison
| Feature | Claya | Vytora Health |
|---|---|---|
| Overall Score | 7.0/10 | ✓8.7/10 |
| Starting Price | $179/mo | ✓$150/mo |
| Editorial Rating | 3.5 ★ /5 | ✓4.4 ★ /5 |
| Features | 7 features | ✓8 features |
| States Available | 0 | ✓51 |
| Compounded | ✓ Yes | ✓ Yes |
| Brand Name | — | ✓ Yes |
| FSA/HSA Accepted | — | — |
| FDA Warnings | None | None |
Pros & Cons
Claya
Pros
- ✓Two named licensed clinicians (Habashy, NMD MS and Barber, MD PhD) — rare transparency for compounded GLP-1
- ✓Two named pharmacy partners with full addresses (RedRock, UT and Healthware, KY)
- ✓Both injectable and oral-tablet forms offered for semaglutide and tirzepatide
- ✓Weight-loss money-back guarantee published on the homepage
- ✓Free expedited shipping included in the monthly price
Cons
- ✗States-served list not disclosed — you must check at checkout
- ✗LegitScript certification status not displayed
- ✗Corporate legal entity not disclosed on the site or privacy policy
- ✗Oral compounded tablets have weaker efficacy data than injectable semaglutide
- ✗Intro pricing is higher at refill ($299), erasing the first-month advantage
Vytora Health
Pros
- ✓All 50 states plus DC, with per-state video-vs-audio compliance disclosed
- ✓Both compounded and brand-name options on one platform — uncommon
- ✓LegitScript Approved and HIPAA compliant
- ✓Pharmacy partners named publicly: Vials Pharmacy (TX) and Greenwich Biosciences
- ✓Operating entity disclosed: Wasef Health, PC (Pinellas Park, FL)
- ✓Competitive monthly pricing ($180 sema / $249 tirz) plus a 3-month bundle saving 17%
- ✓Brand-name Mounjaro and Zepbound available at $1,399/mo for FDA-approved options
Cons
- ✗Brand-name Mounjaro/Zepbound at $1,399/mo is near retail — insured patients may do better via LillyDirect Self Pay ($449-$699/mo)
- ✗Compounded tirzepatide at $249/mo is mid-market, above the $149-199 floor
- ✗Dose tiers aren't broken out — 'all doses included' means low-dose patients pay the same as high-dose
- ✗Initial consultation cost not shown on the public pricing page
- ✗Limited per-prescriber state licensure detail
Our Verdict
Vytora Health edges out Claya with a higher overall score of 8.7/10 and is particularly strong for compounded or brand-name GLP-1 with named pharmacy partners, 50 states. Claya remains a solid alternative, especially if you're looking for compounded GLP-1 in injectable and oral-tablet forms with named clinicians.
Glossary references
Key terms in this article, linked to their canonical definitions.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Related comparisons
Continue exploring Claya and Vytora Health head-to-heads in the same category.
- Claya vs CoreAge Rx
- Claya vs TrimRx
- Claya vs Amazon One Medical
- Vytora Health vs NovoCare Pharmacy
- Vytora Health vs Enhance MD
- Vytora Health vs Noom Med
Or see the full category ranking.
Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.